Samrat Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
234.70
4.7 (2.04%)
BSENSE

Dec 30

BSE+NSE Vol: 320

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024

Compare Balance Sheet Results of Samrat Pharma
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
6.27
-3.18
-50.72%
Share Warrants & Outstandings
Total Reserve
68.71
4.76
63.95
1,343.49%
Shareholder's Funds
71.80
11.04
60.76
550.36%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
2.26
-2.26
-100.00%
Secured Loans
0.00
0.80
-0.80
-100.00%
Unsecured Loans
0.00
1.45
-1.45
-100.00%
Deferred Tax Assets / Liabilities
0.11
-0.02
0.13
650.00%
Other Long Term Liabilities
0.00
0.16
-0.16
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.11
2.39
-2.28
-95.40%
Current Liabilities
Trade Payables
38.70
5.97
32.73
548.24%
Other Current Liabilities
0.94
3.70
-2.76
-74.59%
Short Term Borrowings
9.91
5.00
4.91
98.20%
Short Term Provisions
0.02
0.00
0.02
0.00%
Total Current Liabilities
49.58
14.67
34.91
237.97%
Total Liabilities
121.49
28.10
93.39
332.35%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
1.10
15.75
1,431.82%
Less: Accumulated Depreciation
6.37
0.14
6.23
4,450.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
0.96
9.52
991.67%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.00
3.44
0.00%
Long Term Loans & Advances
0.75
0.00
0.75
0.00%
Other Non Current Assets
3.46
0.00
3.46
0.00%
Total Non-Current Assets
18.13
0.96
17.17
1,788.54%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
0.72
37.29
5,179.17%
Sundry Debtors
56.54
24.55
31.99
130.31%
Cash and Bank
0.16
0.20
-0.04
-20.00%
Other Current Assets
0.17
0.14
0.03
21.43%
Short Term Loans and Advances
8.13
1.55
6.58
424.52%
Total Current Assets
103.36
27.15
76.21
280.70%
Net Current Assets (Including Current Investments)
53.78
12.47
41.31
331.28%
Total Current Assets Excluding Current Investments
103.00
27.15
75.85
279.37%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
28.10
93.39
332.35%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.91
7.26
2.65
36.50%
Book Value per share (adjusted)
232.39
17.60
214.79
1,220.40%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024

Annual - Investments
Investments 3.44 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024

Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024